Loading…
Academic Journal
Controlling Hypertension After Severe Cerebrovascular Event (CHASE): study protocol for a randomized controlled trial
Fang Yuan, Fang Yang, Changhu Xue, Kangjun Wang, Qiuwu Liu, Jun Zhou, Feng Fu, Xiaocheng Wang, Wei Zhang, Yi Liu, Kang Huo, Hua Lv, Wen Jiang, on behalf of the CHASE Study Group
Trials, Vol 19, Iss 1, Pp 1-7 (2018)
Saved in:
| Title | Controlling Hypertension After Severe Cerebrovascular Event (CHASE): study protocol for a randomized controlled trial |
|---|---|
| Authors | Fang Yuan, Fang Yang, Changhu Xue, Kangjun Wang, Qiuwu Liu, Jun Zhou, Feng Fu, Xiaocheng Wang, Wei Zhang, Yi Liu, Kang Huo, Hua Lv, Wen Jiang, on behalf of the CHASE Study Group |
| Publication Year |
2018
|
| Source |
Trials, Vol 19, Iss 1, Pp 1-7 (2018)
|
| Description |
Abstract Background No ideal blood pressure (BP) range has been scientifically determined for acute stroke, and no studies on BP management have been carried out for patients with severe stroke. This trial aims to investigate whether individualized lowering of elevated BP would improve the outcome in patients with severe stroke. Methods/design The CHASE trial is a multicenter, randomized, controlled study. A total of 500 adult patients with acute severe stroke will be enrolled in 18 study sites in China and randomized to individualized BP lowering (10–15% reduction from admission level) or guideline-recommended BP lowering. The primary outcome measurement is the proportion of participants with a poor outcome (modified Rankin Scale ≥ 3) at day 90 of enrollment. Secondary outcomes include disability at hospital discharge and the ability of activities of daily living at day 90 of enrollment. The relationship between intervention and the primary outcome will be analyzed using multivariate logistic regression adjusted for study site, demographics, and baseline characteristics. Discussion The CHASE trial will be the first study to explore the optimum BP management for acute severe stroke. This trial potentially offers a strong argument for individualized target for lowering elevated BP in patients with severe stroke. Trial registration ClinicalTrials.gov, NCT02982655. Registered on 30 November 2016.
|
| Document Type |
article
|
| Language |
English
|
| Publisher Information |
BMC, 2018.
|
| Subject Terms | |
